# Cardiometabolic Effects of Eplerenone in HIV Infection

> **NCT02629094** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 5 (actual)

## Conditions studied

- Cardiac Steatosis
- Hepatic Steatosis

## Interventions

- **DRUG:** Inspra /Eplerenone

## Key facts

- **NCT ID:** NCT02629094
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12-02
- **Primary completion:** 2017-09-11
- **Final completion:** 2017-09-11
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02629094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02629094, "Cardiometabolic Effects of Eplerenone in HIV Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02629094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*